DLA Piper announced today that Erica Kuo has joined the firm's Intellectual Property and Technology practice as of counsel in the New York office.

Kuo has extensive experience across pharmaceutical and biotechnology patent law, with a focus on representing innovator pharmaceutical companies in all stages of patent portfolio acquisition, development and enforcement. Kuo also represented generic pharmaceutical companies on their challenges to Orange Book-listed patents as a partner at her prior firm.

“Along with her valuable legal experience, Erica’s strong chemistry background allows her to represent clients on their most technically challenging life sciences issues,” said Michael Furrow, DLA Piper’s US chair of Life Sciences Patent Strategy. “Erica’s skillset positions her to add tremendous value assisting biopharma companies in preparing for patent challenges on their most important products.”

Kuo, who was previously a partner at Goodwin Procter, received her J.D. from Stanford Law School, her M.S. in chemistry from the University of California, Berkeley, and her B.S. in chemistry from the Massachusetts Institute of Technology.

About DLA Piper (www.dlapiper.com)

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising.